XPO1
History
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
title Publication timing
2017-10-10 : Reddy : DLBCL
2016-03-01 : Mareschal : DLBCL
2016-06-01 : Jardin : PMBL
2018-05-01 : Chapuy : DLBCL
2021-05-05 : Hubschmann : DLBCL
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
| 1 | high-confidence PMBL/cHL/GZL gene1 | |
| 1 | high-confidence DLBCL gene2,3 |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
Cannot include /DLBCL_XPO1.md - does not exist yet
Mutation pattern and selective pressure estimates
| Entity | aSHM | Significant selection | dN/dS (missense) | dN/dS (nonsense) |
|---|---|---|---|---|
| BL | No | No | 1.028 | 0 |
| DLBCL | No | No | 9.927 | 0 |
| FL | No | No | 0.000 | 0 |
XPO1 Hotspots
| Chromosome | Coordinate (hg19) | ref>alt | HGVSp |
|---|---|---|---|
| chr2 | 61719471 | T>C | E571G |
| chr2 | 61719472 | C>T | E571K |
View coding variants in ProteinPaint hg19 or hg38
View all variants in GenomePaint hg19 or hg38
XPO1 Expression
References
1.
Jardin F, Pujals A, Pelletier L, Bohers E,
Camus V, Mareschal S, Dubois S, Sola B, Ochmann M, Lemonnier F, Viailly
PJ, Bertrand P, Maingonnat C, Traverse-Glehen A, Gaulard P, Damotte D,
Delarue R, Haioun C, Argueta C, Landesman Y, Salles G, Jais JP, Figeac
M, Copie-Bergman C, Molina TJ, Picquenot JM, Cornic M, Fest T, Milpied
N, Lemasle E, Stamatoullas A, Moeller P, Dyer MJS, Sundstrom C, Bastard
C, Tilly H, Leroy K. Recurrent mutations of the
exportin 1 gene (XPO1) and their impact on selective
inhibitor of nuclear export compounds sensitivity in primary mediastinal
B-cell lymphoma. Am J Hematol. 2016
Sep;91(9):923–930.
2.
Mareschal S, Dubois S, Viailly PJ, Bertrand P,
Bohers E, Maingonnat C, Jaïs JP, Tesson B, Ruminy P, Peyrouze P,
Copie-Bergman C, Fest T, Jo Molina T, Haioun C, Salles G, Tilly H,
Lecroq T, Leroy K, Jardin F. Whole exome sequencing of
relapsed/refractory patients expands the repertoire of somatic mutations
in diffuse large B-cell lymphoma. Genes
Chromosomes Cancer. 2016 Mar;55(3):251–267.
3.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love
CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg
ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W,
Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y,
Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O,
Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB,
Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava
G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn
A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T,
Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional
Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017
Oct;171(2):481–494.e15. PMCID: PMC5659841


